Llwytho...
Severe Thrombocytopenia in a Patient with COVID-19
Coronavirus disease 2019 (COVID-19) outbreak is spreading rapidly all over the world, being a major threat to public health. Since clinical feature of COVID-19 has not been fully evaluated yet, empirical antibacterial agents are frequently combined for the treatment of COVID-19 in addition to antivi...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Infect Chemother |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7533212/ https://ncbi.nlm.nih.gov/pubmed/32342677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3947/ic.2020.52.3.410 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|